History

Established a research system for the fourth stage of collaborative treatment with Korean and Western medicine pilot project, involving 75 institutions, and operated the monitoring center for clinical research and project evaluation.

Conducted prospective clinical research for the fourth stage of collaborative treatment with Korean and Western medicine (facial paralysis, stroke, knee pain, shoulder pain), with patient registration completed for facial paralysis and stroke, and ongoing recruitment for knee and shoulder pain studies.

Conducted retrospective case studies on convergent treatment technologies for the fourth-stage collaborative treatment with Korean and Western medicine.

Developed clinical practice guidelines for Korean medicine and conducted a systematic literature review to extract collaboration evidence and establish a database.

Conducted research investigating the participating institutions in the fourth stage of collaborative treatment with Korean and Western medicine.

Conducted surveys on patient satisfaction and needs regarding the fourth stage of collaborative treatment with Korean and Western medicine.

Conducted surveys on healthcare professional satisfaction and needs regarding the fourth stage of collaborative treatment with Korean and Western medicine.

Reported on monitoring studies of collaborative treatment for patients in the fourth stage of collaborative treatment with Korean and Western medicine.

Hosted research briefings and symposiums on the fourth stage of collaborative treatment with Korean and Western medicine.

Established a research system for the fourth-stage collaborative treatment with Korean and Western medicine pilot project, involving 75 institutions, and operated the monitoring center for clinical research and project evaluation.

Developed research plans including IRB approval and patient recruitment for prospective clinical research in the fourth stage of collaborative treatment with Korean and Western medicine (facial paralysis, stroke [prior stage], knee pain, shoulder pain [fourth stage])

Conducted retrospective studies to identify convergent treatment technologies in the fourth stage of collaborative treatment with Korean and Western medicine.

Conducted a systematic literature review and established a database on treatment technologies for collaborative treatment with Korean and Western medicine.

Performed research investigating the participating institutions in the fourth stage of collaborative treatment with Korean and Western medicine

Conducted surveys on patient satisfaction and needs regarding the fourth stage of collaborative treatment with Korean and Western medicine.

Conducted surveys on healthcare professional satisfaction and needs regarding the fourth stage of collaborative treatment with Korean and Western medicine.

Reported on monitoring studies of collaborative treatment for patients in the fourth stage of collaborative treatment with Korean and Western medicine.

Completed prospective clinical research for the third stage of collaborative treatment with Korean and Western medicine (lower back pain, facial paralysis, stroke, cervical pain).

Completed retrospective clinical research for the third stage of collaborative treatment with Korean and Western medicine.

Conducted a survey on critical pathways (CP) for institutions participating in the third-stage collaborative treatment with Korean and Western medicine in 2021.

Performed research investigating the participating institutions in the third stage of collaborative treatment with Korean and Western medicine

Conducted surveys on patient satisfaction and needs regarding the third stage of collaborative treatment with Korean and Western medicine.

Conducted surveys on healthcare professional satisfaction and needs regarding the third stage of collaborative treatment with Korean and Western medicine.

Data establishment for extracting recommendations related to clinical practice guidelines for Korean medicine developed in 2021.

Initiated prospective clinical research for the third stage of collaborative treatment with Korean and Western medicine (lower back pain, facial paralysis, stroke, cervical pain) and patient registration.

Developed research plans, including IRB approval and patient recruitment, for the third stage of collaborative treatment with Korean and Western medicine (aggregating EMR data from healthcare institutions by disease group).

Conducted quality assessment research on critical pathways (CP) for institutions participating in the third-stage collaborative treatment with Korean and Western medicine.

Reported on monitoring studies of collaborative treatment for patients in the third stage of collaborative treatment with Korean and Western medicine.

Performed research investigating the institutions involved in the third stage of collaborative treatment with Korean and Western medicine.

Conducted surveys on patient satisfaction and needs regarding the third stage of collaborative treatment with Korean and Western medicine.

Conducted surveys on healthcare professional satisfaction and needs regarding the third stage of collaborative treatment with Korean and Western medicine.

Data establishment for extracting recommendations related to clinical practice guidelines for Korean medicine developed in 2020.

Conducted patient recruitment for a prospective observational study in the second stage of the pilot project for lower back pain, stroke, facial paralysis, and mild cognitive impairment, and disseminated the results.

Completed and reported the findings of retrospective clinical research conducted during the second stage of the pilot project.

Organized a competition as part of the second stage of the Korean and Western Medicine collaboration pilot project, showcasing case studies and exemplary practices.

Established research systems for the third stage of the collaborative treatment pilot project for Korean and Western medicine across 70 institutions, and managed the monitoring center for clinical research and project evaluation.

Developed and distributed collaborative critical pathways (CPs) to support healthcare institutions participating in the third stage of the collaborative treatment pilot project and provided related training.

Designed clinical research models for the third stage of collaborative treatment involving Korean and Western medicine, obtained IRB approval, and initiated studies on clinical effects and institutional-grade-specific outcomes.

Reported on research investigating institutions participating in the third stage of collaborative treatment of Korean and Western medicine.

Conducted surveys assessing patient satisfaction and needs related to the third stage of collaborative treatment with Korean and Western medicine.

Conducted surveys assessing healthcare professional satisfaction and needs regarding the third stage of collaborative treatment with Korean and Western medicine.

Final report on the monitoring center research for the first stage (2015-2019) of collaborative treatment with Korean and Western medicine.

Established research systems for the second stage of the collaborative treatment pilot project for Korean and Western medicine across 45 institutions, and managed the monitoring center for clinical research and project evaluation.

Obtained IRB approval for clinical research at all participating institutions in the second-stage prospective observational study on four diseases (lower back pain, facial paralysis, stroke, and dementia) and initiated the study with an e-CRF setup.

Published a protocol for a prospective observational study on lower back pain and mild cognitive impairment in an SCI-indexed journal.

Developed the CRF, obtained IRB approval for the retrospective observational study, and registered it with CRIS.

Reported on research investigating the institutions participating in the second stage of collaborative treatment with Korean and Western medicine in 2018.

Conducted surveys on patient satisfaction and needs regarding the second stage of collaborative treatment with Korean and Western medicine in 2018.

Conducted surveys on healthcare professional satisfaction and needs regarding the second stage of collaborative treatment with Korean and Western medicine.

Conducted a systematic literature review on treatment technologies for collaborative treatment with Korean and Western medicine, and published the protocol paper in an SCI journal.

Conducted economic evaluations and clinical research to generate evidence for Chuna therapy.

Conducted economic evaluations and clinical research to develop clinical practice guidelines for facial nerve paralysis.

Conducted economic evaluations and clinical research on treatment technologies for clinical practice guidelines targeting cancer patients.

Conducted economic evaluations and clinical research on herbal treatments for appetite loss in cancer patients.

Conducted economic evaluations and clinical research on treatment technologies for clinical practice guidelines addressing postoperative syndrome.

Established research systems for the first stage of the collaborative treatment pilot project with Korean and Western medicine across 75 institutions and operated the monitoring center for clinical research and project evaluation.

Reported the analysis of prospective registration studies for patients in the first stage of the collaborative treatment pilot project for Korean and Western medicine.

Reported the analysis of retrospective data from the Health Insurance Review and Assessment Service for patients in the first stage of the collaborative treatment pilot project.

Conducted surveys to assess patient satisfaction and needs regarding the first stage of collaborative treatment with Korean and Western medicine.

Conducted surveys to evaluate healthcare professional satisfaction and needs regarding the first stage of collaborative treatment with Korean and Western medicine.

Conducted research to develop reimbursement rates for the second stage of the collaborative treatment pilot project for Korean and Western medicine.

Performed financial estimation studies for the second stage of the pilot project.

Developed plans for prospective clinical research for the second stage of collaborative treatment with Korean and Western medicine.

Created a standard manual for the second stage of collaborative treatment with Korean and Western medicine.

Hosted two research briefings and symposiums for the second stage of the collaborative treatment pilot project.

Conducted economic evaluations and clinical research on treatment for allergic rhinitis.

Performed economic evaluations and clinical research for clinical practice guidelines addressing traffic accident injury syndrome.

Established research systems for institutions participating in the pilot project for collaborative treatment with Korean and Western medicine and operated the monitoring center for clinical research and project evaluation.

Created a website for the monitoring center to support collaborative treatment with Korean and Western medicine.

Conducted financial estimation studies for the first stage of the collaborative treatment pilot project with Korean and Western medicine.

Developed patient registration research protocols for the first stage of the pilot project for collaborative treatment with Korean and Western medicine.

Obtained IRB approval, registered with CRIS, and developed an e-CRF (KCDC) for clinical research at 12 healthcare institutions participating in the first stage of the collaborative treatment pilot project.

Performed retrospective clinical research as part of the first stage of the collaborative treatment pilot project with Korean and Western medicine.

Conducted research on the operational status of healthcare institutions involved in the first stage of the pilot project for collaborative treatment.

Operated a support system for big data analysis related to collaborative treatment at the Health Insurance Review and Assessment Service.

Hosted a symposium on collaborative treatment (complementary and alternative medicine) in collaboration with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Established a big data analysis system for healthcare.

Completed the formation of a multidisciplinary research advisory group.

Research network for collaborative treatment with Korean and Western medicine (13 hospitals).

Developed SOPs for diseases targeted by collaborative treatment with Korean and Western medicine.

Developed preliminary research plans.

Conducted qualitative research to define collaborative treatment practices between Korean and Western medicine.

Analyzed priority diseases for collaborative treatment with Korean and Western medicine using big data from the Health Insurance Review and Assessment Service.